Total Funding
58
50
Total FundingSeries A raised
Growth Score 58 in past quarter
-3 pts
Heat Score 50 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
23417
VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials.
- Jo Varshney: Founder & CEO
Ted Ira: Vice President, Global Sales & StrategyPast Role: Biomere, Head of Sales and Business Development
About the Company
VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. VeriSIM offers a range of translational-based solutions, customized for the pre-clinical and clinical programs. These offerings are all centered around their proven and validated BIOiSIMTM platform for small molecules, large
molecules, and viruses.
Women Founded
Women Led